Jean J M C H de la Rosette
Overview
Explore the profile of Jean J M C H de la Rosette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
2801
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muderrisoglu A, de la Rosette J, Michel M
Expert Opin Drug Saf
. 2023 Dec;
22(12):1213-1224.
PMID: 38064204
Introduction: The drug classes of α-adrenoceptor antagonists, 5α-reductase inhibitors, and phosphodiesterase type 5 inhibitors are guideline-recommended treatments of lower urinary tract symptoms suggestive of benign prostatic hyperplasia; muscarinic receptor antagonists...
2.
Gravas S, Malde S, Cornu J, Gacci M, Gratzke C, Herrmann T, et al.
Prostate Cancer Prostatic Dis
. 2023 Jul;
27(1):48-53.
PMID: 37488274
No abstract available.
3.
Muderrisoglu A, Sakul A, Murgas S, de la Rosette J, Michel M
Front Pharmacol
. 2023 Apr;
14:1144470.
PMID: 37063295
Pelvic hypoperfusion caused by atherosclerosis has been proposed as a cause of lower urinary tract dysfunction including overactive bladder syndrome (OAB). Limited data indicate that OAB patients with concomitant diabetes...
4.
Michel M, Heemann U, de la Rosette J
Front Pharmacol
. 2022 Dec;
13:1081074.
PMID: 36582525
While animal studies have suggested an association between the presence of hypertension and the presence and/or severity of overactive bladder syndrome (OAB) symptoms, little clinical data is available. We have...
5.
Reddy S, Reddy B, Chawla A, de la Rosette J, Laguna P, Hegde P, et al.
J Clin Med
. 2022 Dec;
11(23).
PMID: 36498598
Ureteric stent insertion following ureteroscopic lithotripsy (URSL) is a common and widely accepted procedure. However, there is no agreement on whether a ureteric stent should be placed following an uncomplicated...
6.
Muderrisoglu A, Oelke M, Schneider T, Murgas S, de la Rosette J, Michel M
Adv Ther
. 2022 Mar;
39(6):2489-2501.
PMID: 35325367
Introduction: Unmet expectations are a major cause of perceived treatment failure and discontinuation of treatment. To enable evidence-based counselling of patients on realistic expectations, we determined the chance of patients...
7.
Kriplani A, Pandit S, Chawla A, de la Rosette J, Laguna P, Reddy S, et al.
Urolithiasis
. 2022 Mar;
50(3):341-348.
PMID: 35246692
The objective of this prospective observational study was to assess the clinical significance of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) as potential biomarkers to identify post-PNL...
8.
Chawla A, Bhaskara S, Taori R, de la Rosette J, Laguna P, Pandey A, et al.
Ther Adv Urol
. 2022 Feb;
14:17562872221078773.
PMID: 35222694
Introduction: Emphysematous pyelonephritis (EPN), an acute necrotizing infection of the kidney and surrounding tissues, is associated with considerable mortality. We evaluated how existing critical care scoring systems could predict the...
9.
Shah M, Pillai S, Chawla A, de la Rosette J, Laguna P, Reddy S, et al.
BJU Int
. 2021 Jul;
129(3):373-379.
PMID: 34245667
Objective: To compare stent-related symptoms (SRS) associated with conventional ureteric JJ stent (CUS) placement and SRS associated with placement of a modified complete intra-ureteric stent (CIUS) with extraction suture, designed...
10.
de la Rosette J, Salas R, Rastinehad A, Polascik T
World J Urol
. 2021 Mar;
39(3):635-636.
PMID: 33649870
No abstract available.